Page 40 - Markets

Kalpataru Projects jump 6% post Q1; brokerages bullish on strong order book

The company reported a 974 per cent Y-o-Y rise in consolidated net profit to ₹430.60 crore for the quarter, compared with ₹218.17 crore in the year-ago period.

Ardee Industries makes strong debut, shares list at 39% premium

Ardee Industries shares opened at ₹72 on the NSE, up ₹19 apiece or 35.85 per cent, compared with the IPO issue price of ₹53. On the BSE, the shares debuted at ₹73.60, up ₹20.60 or 38.87 per cent.

Manappuram Finance up 3% as Q1 PAT jumps 4x; gold loan AUM nearly doubles

Manappuram Finance reported consolidated profit of Rs 585 crore for the first quarter ended June 30, 2026, compared to a profit of Rs 132 crore in the corresponding quarter of the previous year.

Nifty faces 24,500 hurdle; Divi's Labs, MCX, Eternal on analyst radar

Chandan Taparia of Motilal Oswal Financial Services has recommended three stocks to buy today: Divi's Laboratories, MCX, and Eternal.

Stock Market Close: Sensex falls 388 pts, Nifty settles at 24,472; FMCG, realty, cement shares weigh

Sensex Today | Stock Market LIVE Updates Tuesday: The GIFT Nifty signalled a negative open for the Nifty50. Most Asian markets were trading higher

Oil India shares rally 7% as brokerages turn bullish after Q1 results

Crude production rose 11 per cent Y-o-Y to 0.95 mmt, with the current run-rate higher at 11ktpd.

Chennai Petroleum, MRPL surge up to 13% in weak market on huge volume

Share price of CPCL hit a new high of ₹1,404.90, soaring 13 per cent on the BSE on the back of six-fold jump in the average trading volume on Tuesday.

Shiprocket IPO: Solid GMP, decent valuations but analysts split; here's why

Swastika said Shiprocket IPO is best suited for high-risk, growth-oriented portfolios with a 2-3-year horizon rather than conservative value investors.

Paytm up 428% from its low; Bernstein sees more headroom; tech view here

Paytm stock surged 71% thus far in FY27, and a whopping 429% from its all-time low of ₹310 in May 2024. Tech analyst at YES Securities reckons that the stock can possibly test the IPO price from here.

Molbio Diagnostics IPO fully subscribed on day 2; NIIs lead with 3x bids

The company's IPO garnered bids for 1,83,79,566 shares against 81,58,529 shares on offer, as per BSE data.

Info Edge extends rally, surges 13% in two days on heavy volume post Q1

Q1FY27 marks a meaningful improvement in Info Edge's growth trajectory, although the sustainability of recruitment volume growth and Shiksha's traffic headwinds remain key monitorables, say analysts.

Swan Defence zooms 620% in a year; is this stupendous rally sustainable?

Notably, Swan Defence acquired Reliance Naval and Engineering in 2023, and shares of the shipbuilding and heavy engineering firm recommenced trading on the bourses in January 2025.

Vodafone Idea share price rises 3% on narrower losses in Q1, rise in Arpu

Vodafone Idea share price gained 3 per cent to hit ₹13.30 against the last closing price of ₹12.91 apiece on the BSE. This marks the third straight day of gains for the stock.

OFS forms 61% of ₹2.3trn IPO proceeds in 1.5 yrs; why're promoters selling?

In 2025 alone, 113 issues raised around ₹1.7 trillion, of which October was the biggest month, with 10 IPOs raising ₹45,188 crore, including a massive ₹35,441 crore through OFS.

Triveni Turbine shares tumble 8% after Q1 profit drops 20%, margins shrink

Triveni Turbine has reported a net profit of ₹51.1 crore in Q1FY27, down 20 per cent from ₹64.4 crore posted in the year-ago period.

MF schemes with 10%+ gains fall by 3/4th in FY26; is easy money era over?

Sebi's annual report for financial year 2025-26 (FY26) shows that 198 schemes delivered 10 per cent-plus gains in the last fiscal year, as against 304 in FY25 and a whopping 822 in FY24.

Dhoot Transmission or Molbio: Which IPO should investors subscribe to?

Dhoot Transmission and Molbio Diagnostics offer investors exposure to two different growth themes. EV components and molecular diagnostics.

HDFC Bank stock hits 2-year low, tanks 12% in one month

HDFC Bank stock: Thus far in the calendar year 2026, HDFC Bank underperformed the market by falling 27 per cent, compared to a 8.2 per cent decline in the BSE Sensex.

Gland Pharma rallies 12%, stock hits 4-year high post Q1 results

Gland Pharma Share: The market price of Gland Pharma hit a high of ₹2,989.2 in intra-day deals on Tuesday. The stock bounced back 90 per cent from its 52-week low of ₹1,575 touched on March 16, 2026.

ZEEL shares drop 5% as weak ad revenue drags Q1 profit by 48%

Analysts at Motilal Oswal Financial Services said ZEEL delivered another subdued quarter. The firm's consolidated profit in Q1 declined by 48.3 per cent to ₹74.3 crore.